Home
EMBC
EMBC News

Latest Embecta Corp. (EMBC) News on November 25, 2025

embecta announces changes to Board of Directors

GlobeNewswire

7 days ago

embecta announces changes to Board of Directors

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

ACCESS Newswire

11 days ago

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

MT Newswires

11 days ago

Embecta Expands Partnership With Direct Relief to Support Global Diabetes Care

embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

13 days ago

embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

Is Embecta Corp. (NASDAQ:EMBC) Potentially Undervalued?

Simply Wall St.

25 days ago

Is Embecta Corp. (NASDAQ:EMBC) Potentially Undervalued?

Is Embecta Corp. (NASDAQ:EMBC) Trading At A 48% Discount?

Simply Wall St.

2 months ago

Is Embecta Corp. (NASDAQ:EMBC) Trading At A 48% Discount?

Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges

Insider Monkey

5 months ago

Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges

Argus Research

5 months ago

EMBC: Raising target price to $11.00

embecta to Participate in Investor Events

GlobeNewswire

6 months ago

embecta to Participate in Investor Events

Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock

Simply Wall St.

6 months ago

Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock

Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15

Simply Wall St.

6 months ago

Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

GlobeNewswire

6 months ago

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

Argus Research

6 months ago

EMBC: What does Argus have to say about EMBC?

Embecta restructures again, outlines tariff costs

MedTech Dive

6 months ago

Embecta restructures again, outlines tariff costs

Embecta Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Embecta Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Thomson Reuters StreetEvents

6 months ago

Q2 2025 Embecta Corp Earnings Call

GuruFocus.com

6 months ago

Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline

Why Is Embecta Stock Falling On Friday?

Benzinga

7 months ago

Why Is Embecta Stock Falling On Friday?

Embecta Corp. (EMBC) Tops Q2 Earnings Estimates

Zacks

7 months ago

Embecta Corp. (EMBC) Tops Q2 Earnings Estimates

3 Undervalued Small Caps With Insider Activity Across Global Markets

Simply Wall St.

7 months ago

3 Undervalued Small Caps With Insider Activity Across Global Markets

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

GlobeNewswire

7 months ago

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)?

Simply Wall St.

7 months ago

Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)?

embecta Announces Quarterly Cash Dividend

GlobeNewswire

7 months ago

embecta Announces Quarterly Cash Dividend

Argus Research

7 months ago

EMBC: What does Argus have to say about EMBC?

Embecta to host Analyst and Investor Day on May 22, 2025

GlobeNewswire

7 months ago

Embecta to host Analyst and Investor Day on May 22, 2025

Argus Research

7 months ago

EMBC: Lowering target price to $12.00

Beyond the drug: Closing the knowledge gap for injectable diabetes meds

Pharma Voice

7 months ago

Beyond the drug: Closing the knowledge gap for injectable diabetes meds

embecta to Report Fiscal Second Quarter 2025 Financial Results

GlobeNewswire

7 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

Argus Research

7 months ago

EMBC: Raising target price to $13.00

MT Newswires

7 months ago

Mizuho Initiates Embecta at Neutral With $15 Price Target

Argus Research

8 months ago

EMBC: Lowering target price to $12.00

Argus Research

8 months ago

EMBC: What does Argus have to say about EMBC?

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

GlobeNewswire

8 months ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Undervalued Small Caps With Insider Action Across Regions In April 2025

Simply Wall St.

8 months ago

Undervalued Small Caps With Insider Action Across Regions In April 2025

Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Simply Wall St.

8 months ago

Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Argus Research

8 months ago

EMBC: Lowering target price to $13.00

Argus Research

9 months ago

EMBC: Lowering target price to $13.00

Embecta Insider Ups Holding By 20% During Year

Simply Wall St.

9 months ago

Embecta Insider Ups Holding By 20% During Year

Argus Research

9 months ago

EMBC: Lowering target price to $14.00

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

Insider Monkey

9 months ago

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

Argus Research

9 months ago

EMBC: Lowering target price to $16.00

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

GlobeNewswire

9 months ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

GuruFocus.com

10 months ago

Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

MT Newswires

10 months ago

Embecta's Fiscal Q1 Adjusted Earnings Rise, Revenue Declines

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Zacks

10 months ago

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire

10 months ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

embecta Announces Quarterly Cash Dividend

GlobeNewswire

10 months ago

embecta Announces Quarterly Cash Dividend

Argus Research

10 months ago

EMBC: Lowering target price to $19.00

embecta to Report Fiscal First Quarter 2025 Financial Results

GlobeNewswire

10 months ago

embecta to Report Fiscal First Quarter 2025 Financial Results

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

Zacks

10 months ago

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Zacks

10 months ago

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Argus Research

10 months ago

EMBC: Rating increased to a HOLD

Argus Research

10 months ago

EMBC: What does Argus have to say about EMBC?

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

Zacks

a year ago

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

3 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks

a year ago

3 Stocks Trading Near 52-Week High With Room to Rise Further

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

Zacks

a year ago

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

Zacks

a year ago

Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC)

Zacks

a year ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC)

Embecta to cut 125 jobs after ending insulin patch pump

MedTech Dive

a year ago

Embecta to cut 125 jobs after ending insulin patch pump

Argus Research

a year ago

EMBC: Raising target price to $16.00

Best Value Stocks to Buy for December 2nd

Zacks

a year ago

Best Value Stocks to Buy for December 2nd

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?

Simply Wall St.

a year ago

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?

MT Newswires

a year ago

BTIG Research Upgrades Embecta to Buy From Neutral, $26 Price Target

Embecta to discontinue insulin patch pump program, initiates restructuring plan

TipRanks

a year ago

Embecta to discontinue insulin patch pump program, initiates restructuring plan

GuruFocus.com

a year ago

Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance

Thomson Reuters StreetEvents

a year ago

Q4 2024 Embecta Corp Earnings Call

Argus Research

a year ago

EMBC: Raising target price to $15.00

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps

Benzinga

a year ago

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps

Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates

Zacks

a year ago

Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates

MT Newswires

a year ago

Embecta Fiscal Q4 Adjusted Earnings Decline, Revenue Increases; Fiscal 2025 Guidance Issued

MT Newswires

a year ago

Embecta Discontinues Insulin Patch Pump Program, Initiates Organizational Restructuring Plan

Embecta discontinues insulin patch pump development

MedTech Dive

a year ago

Embecta discontinues insulin patch pump development

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

GlobeNewswire

a year ago

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

embecta Announces Quarterly Cash Dividend

GlobeNewswire

a year ago

embecta Announces Quarterly Cash Dividend

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

a year ago

Inside a $400 billion bet on the brain-computer interface revolution

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

a year ago

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

a year ago

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

GlobeNewswire

a year ago

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump

Zacks

a year ago

Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump

MT Newswires

a year ago

Sector Update: Health Care Stocks Retreat in Afternoon Trading

MT Newswires

a year ago

Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes

Embecta gets FDA nod for insulin patch pump

MedTech Dive

a year ago

Embecta gets FDA nod for insulin patch pump

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

GlobeNewswire

a year ago

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

embecta to Participate in Investor Events

GlobeNewswire

a year ago

embecta to Participate in Investor Events

Argus Research

a year ago

EMBC: What does Argus have to say about EMBC?

Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

a year ago

Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Simply Wall St.

a year ago

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average

Zacks

a year ago

Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average

Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average

Zacks

a year ago

Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average

Embecta Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Embecta Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

a year ago

Embecta Shares Rise After Fiscal Q3 Beat; Fiscal 2024 EPS Guidance Raised

Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates

Zacks

a year ago

Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates

Share on Social Networks: